What This Longevity Investor Knows That You Don't | Karl Pfleger, Founder of AgingBiotech.info, Co-Hosted with Dr. Greg Bailey, Chairman of Juvenescence
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Why senolytics are the most promising near-term area
Karl highlights senescent cell clearance (senolytics) as a leading, actionable approach likely to deliver early clinical successes.
Transcript
Play full episode
